Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors affecting high-density lipoproteins

D J Gordon1

  • 1National Heart, Lung, and Blood Institute, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Endocrinology and Metabolism Clinics of North America
|October 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally invasive surgery for severe hallux valgus in 106 feet.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2022
Same author

Time to maximum clinical improvement following minimally invasive chevron and Akin osteotomies (MICA) in hallux valgus surgery.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2022
Same author

The impact of hallux valgus on function and quality of life in females.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2021
Same author

Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells.

Oncogene·2015
Same author

The outcome at 15 years of endoscopic anterior cruciate ligament reconstruction using hamstring tendon autograft for 'isolated' anterior cruciate ligament rupture.

The Journal of bone and joint surgery. British volume·2012
Same author

Male breast cancer in World War II aviation: a case report and review.

Breast (Edinburgh, Scotland)·2003
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Low high-density lipoprotein (HDL) cholesterol is linked to coronary heart disease (CHD), but its causal role is unproven. Current interventions focus on lowering low-density lipoprotein cholesterol for better CHD risk management.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • Low high-density lipoprotein (HDL) cholesterol is a known risk factor for atherosclerotic coronary heart disease (CHD).
  • The causal link between low HDL cholesterol and CHD development requires further investigation.
  • HDL cholesterol levels often correlate with other modifiable CHD risk factors.

Purpose of the Study:

  • To evaluate the established association between low HDL cholesterol and CHD risk.
  • To assess the efficacy and safety of interventions targeting HDL cholesterol levels.
  • To guide clinical recommendations for CHD prevention strategies.

Main Methods:

  • Review of existing epidemiological data and clinical studies on HDL cholesterol and CHD.

Related Experiment Videos

  • Analysis of the impact of lifestyle modifications and pharmacologic agents on HDL cholesterol.
  • Assessment of the evidence for a causal relationship between HDL cholesterol levels and CHD outcomes.

    • Main Results:

    • A strong association exists between low HDL cholesterol and increased CHD risk, but causality is not definitively established.
    • Lifestyle changes can mitigate CHD risk and may influence HDL cholesterol levels.
    • No specific, safe, and effective drugs are currently available for raising HDL cholesterol to prevent CHD.

    Conclusions:

    • Routine measurement of HDL cholesterol is recommended for cardiovascular risk assessment.
    • Current evidence suggests focusing interventions on lowering low-density lipoprotein cholesterol for primary CHD prevention.
    • Further research is needed to clarify the therapeutic potential of targeting HDL cholesterol.